Clinical trial
Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
NCT00167544 · Nationwide Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00167544 |
|---|---|
| Title | Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants |
| Official title | A Randomized Trial of Hydrocortisone in Very Preterm Infants at High Risk for Neurologic and Pulmonary Impairments |
| Lead sponsor | Nationwide Children's Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Neurological Disorders and Stroke (NINDS) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bronchopulmonary Dysplasia, Encephalomalacia, Premature Birth |
| Intervention type | Drug |
| Interventions | Hydrocortisone, Placebo |
| Enrollment | 64 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Nov 1, 2012 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: